Skybiotech Healt

Market Cap: Micro Cap
Industry: Garments & Apparels
ISIN: INE393H01016
NSEID:
BSEID: 512036
View on BSE

INR

155.65

-8.15 (-4.98%)

BSENSE

Mar 20

BSE+NSE Vol: 2

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sparkle GoldRock

STL Global

Swasti Vinayaka

Skybiotech Healt

Katare Spinning

Akshar Spintex

Tusaldah

Avax Apparels

United Cotfab

Cedaar Textile

Paramount Dye

Why is Skybiotech Healthcare Limited ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at -1.44% over the last 5 years
Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times

Flat results in Dec 25

ROCE(HY) Lowest at -2.04%

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 3.11%, its profits have fallen by -101%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Garments & Apparels)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Skybiotech Healt for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Skybiotech Healt

3.11%

0.05

63.35%

Sensex

-1.97%

-0.15

12.70%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-1.44%

EBIT to Interest (avg)

-1.47

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.83

Sales to Capital Employed (avg)

Tax Ratio

2.47%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

-2.25%

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.49

EV to EBIT

-13.87

EV to EBITDA

-17.18

EV to Capital Employed

2.36

EV to Sales

5.51

PEG Ratio

Dividend Yield

ROCE (Latest)

-17.01%

ROE (Latest)

-26.36%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET SALES(9M)

Higher at Rs 5.27 cr

-2What is not working for the Company

ROCE(HY)

Lowest at -2.04%

Loading Valuation Snapshot...

Here's what is working for Skybiotech Healt

Net Sales - Nine Monthly

At Rs 5.27 cr has Grown at 27.91%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Nine Monthly

Higher at Rs 5.27 cr

than preceding 12 month period ended Dec 2025 of Rs 5.14 cr

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (Rs Cr)